Eulav Asset Management ALEXION PHARMACEUTICALS INC Transaction History

Eulav Asset Management

$3.7 Billion
Q2 2024

Shares

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 30, 2021	SELL	N/A	-148,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	N/A	-74,000 Reduced 33.33%	148,000 $23.1 Million
Q3 2020 Nov 05, 2020	BUY	N/A	82,000 Added 58.57%	222,000 $25.4 Million
Q2 2020 Aug 11, 2020	SELL	N/A	-37,000 Reduced 20.9%	140,000 $15.7 Million
Q1 2020 Apr 27, 2020	SELL	N/A	-65,200 Reduced 26.92%	177,000 $15.9 Million
Q4 2019 Feb 13, 2020	SELL	N/A	-30,000 Reduced 11.02%	242,200 $26.2 Million
Q3 2019 Nov 12, 2019	BUY	N/A	10,000 Added 3.81%	272,200 $26.7 Million
Q2 2019 Aug 05, 2019	BUY	N/A	5,000 Added 1.94%	262,200 $34.3 Million
Q1 2019 May 13, 2019	SELL	N/A	-90,800 Reduced 26.09%	257,200 $34.8 Million
Q4 2018 Feb 14, 2019	BUY	N/A	38,000 Added 12.26%	348,000 $33.9 Million
Q3 2018 Oct 26, 2018	SELL	N/A	-77,000 Reduced 19.9%	310,000 $43.1 Million
Q2 2018 Aug 14, 2018	BUY	N/A	15,000 Added 4.03%	387,000 $48 Million
Q1 2018 May 09, 2018	SELL	N/A	-33,000 Reduced 8.15%	372,000 $41.5 Million
Q4 2017 Feb 14, 2018	BUY	N/A	18,000 Added 4.65%	405,000 $48.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	387,000	387,000 $47.1 Million

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eulav Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eulav Asset Management with notifications on news.